Stocktoria
Co-Diagnostics, Inc. CODX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2017-07-12
Co-Diagnostics, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $622,489 | $3.9M | $6.8M | $34.2M | $97.9M |
| Gross profit | $400,112 | $2.9M | $2.6M | $28.7M | $86.3M |
| R&D expense | $19.1M | $21.0M | $23.0M | $17.4M | $15.0M |
| Operating income | -$50.2M | -$40.1M | -$42.7M | -$27.0M | $46.1M |
| Income tax | -$1.6M | $57,368 | -$2.8M | -$4.6M | $9.0M |
| Net income | -$46.9M | -$37.6M | -$35.3M | -$14.2M | $36.7M |
| EPS (diluted) | $-35.25 | $-37.22 | $-1.20 | $-0.45 | $1.23 |
| Operating cash flow | -$29.1M | -$29.2M | -$22.1M | $6.6M | $41.1M |
| Free cash flow | -$29.8M | -$29.9M | -$23.4M | $5.1M | $40.4M |
| Cash & equivalents | $11.9M | $2.9M | $14.9M | $23.0M | $88.6M |
| Inventory | $992,397 | $1.1M | $1.7M | $5.3M | $2.0M |
| Total assets | $24.7M | $63.6M | $95.3M | $123.1M | $160.0M |
| Total liabilities | $4.1M | $9.7M | $9.3M | $8.6M | $25.6M |
| Shareholders' equity | $20.6M | $53.9M | $85.6M | $114.5M | $134.5M |
Source: SEC EDGAR filings · CIK 0001692415 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.